[Combantrin-Pfizer in the treatment of enterobiasis detected during mass screening].
D000328:Adult; D000969:Antinematodal Agents / Q000627:therapeutic use*; D002648:Child; D002656:Child Day Care Centers; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D008403:Mass Screening; D010123:Oxyuriasis / Q000188:drug therapy* / Q000517:prevention & control; D011044:Poland; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000627:therapeutic use*; D012572:School Health Services
D000969:Antinematodal Agents; D011715:Pyrantel; D011716:Pyrantel Pamoate
Combantrin--Pfizer w leczeniu owsicy wykrywanej w badaniach środowiskowych.